Cargando…

Real‐world utility of next‐generation sequencing for targeted gene analysis and its application to treatment in lung adenocarcinoma

PURPOSE: This study investigated the clinical utility of next‐generation sequencing (NGS) for detection of genetic alterations and its implications on treatment of lung adenocarcinoma in real‐world practice. PATIENTS AND METHODS: Data were reviewed for 391 patients with lung adenocarcinoma who under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jwa Hoon, Yoon, Shinkyo, Lee, Dae Ho, Jang, Se Jin, Chun, Sung‐Min, Kim, Sang‐We
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124124/ https://www.ncbi.nlm.nih.gov/pubmed/33960703 http://dx.doi.org/10.1002/cam4.3874

Ejemplares similares

The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study
por: Kim, Jwa Hoon, et al.
Publicado: (2021)

Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective study
por: Choi, Myeong Geun, et al.
Publicado: (2021)

Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung
por: Jang, Yoon Jung, et al.
Publicado: (2021)

An oncogenic CTNNB1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinoma
por: Kim, Yeseul, et al.
Publicado: (2023)

Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer
por: Cho, Su Han, et al.
Publicado: (2021)

Clinical Application of Next-Generation Sequencing in Patients With Breast Cancer: Real-World Data
por: Suh, Koung Jin, et al.
Publicado: (2022)

Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing
por: Chun, You Jin, et al.
Publicado: (2019)

Impact of pseudoprogression and treatment beyond progression on outcome in patients with non-small cell lung cancer treated with immune checkpoint inhibitors
por: Won, Sang Eun, et al.
Publicado: (2020)

Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non‐small‐cell lung cancer harboring EGFR mutations: Results from a real‐world study in South Korea
por: Kim, Taeyun, et al.
Publicado: (2021)

Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment
por: Chakraborty, Kasturee, et al.
Publicado: (2022)

Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma
por: Mack, Philip C, et al.
Publicado: (2022)

PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence
por: Byeon, Seonggyu, et al.
Publicado: (2020)

Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteria
por: Roh, Yun Hwa, et al.
Publicado: (2023)

Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor Treatment
por: Jang, Yoon Jung, et al.
Publicado: (2023)

Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real‐world experience
por: Jeon, Young‐Woo, et al.
Publicado: (2019)

Real‐world prognostic factors for survival among treated patients with metastatic pancreatic ductal adenocarcinoma
por: Yu, Kenneth H., et al.
Publicado: (2021)

Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasis
por: Hyun, Dong-gon, et al.
Publicado: (2020)

Comparison of T790M Acquisition Between Patients Treated with Afatinib and Gefitinib as First-Line Therapy: Retrospective Propensity Score Matching Analysis
por: Yoon, Byung Woo, et al.
Publicado: (2019)

Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma
por: Nazha, Bassel, et al.
Publicado: (2022)

Real-world data analysis of patients with cancer of unknown primary
por: Kang, Sora, et al.
Publicado: (2021)

Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma
por: Kim, Hyun-Young, et al.
Publicado: (2022)

Real‐world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma
por: de Jong, Evelien J. M., et al.
Publicado: (2021)

Impact of gender on response to immune checkpoint inhibitors in patients with non-small cell lung cancer undergoing second- or later-line treatment
por: Choi, Myeong Geun, et al.
Publicado: (2022)

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
por: Fox, Alan J., et al.
Publicado: (2016)

Virome assembly and annotation in brain tissue based on next‐generation sequencing
por: Yuan, Zihao, et al.
Publicado: (2020)

Perception and safety analysis of COVID‐19 vaccination in cancer patients: A multicenter, real‐world study
por: Lee, Kyoungmin, et al.
Publicado: (2022)

Clinical impact of rebiopsy among patients with epidermal growth factor receptor‐mutant lung adenocarcinoma in a real‐world clinical setting
por: Nam, Yunha, et al.
Publicado: (2021)

Determination of ETV6‐RUNX1 genomic breakpoint by next‐generation sequencing
por: Jin, Yanliang, et al.
Publicado: (2015)

Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group
por: Yoon, Shinkyo, et al.
Publicado: (2022)

ERRATUM: Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group
por: Yoon, Shinkyo, et al.
Publicado: (2023)

Lipocalin 2 potentially contributes to tumorigenesis from colitis via IL-6/STAT3/NF-κB signaling pathway
por: Kim, Se Lim, et al.
Publicado: (2022)

Umbilical metastases: Real‐world data shows abysmal outcome
por: Hugen, Niek, et al.
Publicado: (2021)

Good Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests
por: Kim, Jihun, et al.
Publicado: (2017)

Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors
por: Kang, Minsu, et al.
Publicado: (2022)

Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma
por: Kim, In Ae, et al.
Publicado: (2020)

Targeted next‐generation sequencing of 22 mismatch repair genes identifies Lynch syndrome families
por: Talseth‐Palmer, Bente A., et al.
Publicado: (2016)

Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States
por: Abdel-Rahman, Omar, et al.
Publicado: (2018)

Next‐generation sequencing in precision oncology: Patient understanding and expectations
por: Roberts, J. Scott, et al.
Publicado: (2019)

FOLFIRINOX or gemcitabine/nab‐paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision‐making in real‐world
por: Marschner, Norbert, et al.
Publicado: (2022)

The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery
por: Jeong, Hyehyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_18dbhlu4ohb6ui99n2vupjepu3